METHODS	Three patients ( 3 % ) of Group A and 5 ( 5 % ) of Group B interrupted therapy for side effects ; 5 patients ( 5.5 % ) of Group C with supraventricular tachycardia interrupted the double blind therapy ; 11 were lost to follow-up .\